VitaSpring Biomedical Co. Ltd.
VSBC
$1.00
$0.000.00%
OTC PK
| 10/31/2022 | 07/31/2022 | 04/30/2022 | 01/31/2022 | 10/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 4,168.26% | 791.46% | 859.22% | 397.23% | 60.88% |
| Total Depreciation and Amortization | 230.43% | 1,800.00% | -- | -- | 4,500.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.47% | -8.53% | 46.79% | 9.95% | 3,127.59% |
| Change in Net Operating Assets | -444.09% | -3,974.31% | -3,075.40% | -3,170.92% | -499.23% |
| Cash from Operations | -220.72% | -207.59% | -195.66% | 301.18% | 14,100.00% |
| Capital Expenditure | 100.00% | 53.41% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 53.41% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -45.05% | -45.05% | -45.05% | -45.05% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -42.86% | -42.86% | -42.86% | -42.86% | 11,037.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -189.03% | -196.59% | -180.59% | 36.34% | 35,466.67% |